{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-005899","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2026-08-03T12:52:10+00:00","discovered_at":"2026-08-03T12:55:03.276657+00:00","generated_at":"2026-08-03T12:55:08.649098+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Sunshine Biopharma reduces Series B warrant exercise price to $1.2202 after ATM sales","bullets":["Exercise price of Series B warrants reduced to $1.2202 due to recent common stock sales under ATM offering.","Adjustment triggered by anti-dilution provisions in the warrant terms.","Further adjustments may occur as set forth in the Series B warrant agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-005899","json":"https://secwatch.observer/filing/0001683168-26-005899.json","markdown":"https://secwatch.observer/filing/0001683168-26-005899.md","text":"https://secwatch.observer/filing/0001683168-26-005899.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826005899/0001683168-26-005899-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826005899/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T12:55:08.649098+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}